These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8619867)

  • 1. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.
    Choubey D; Gutterman JU
    Biochem Biophys Res Commun; 1996 Apr; 221(2):396-401. PubMed ID: 8619867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p202 levels are negatively regulated by serum growth factors.
    Geng Y; D'Souza S; Xin H; Walter S; Choubey D
    Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
    Datta B; Li B; Choubey D; Nallur G; Lengyel P
    J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities.
    Min W; Ghosh S; Lengyel P
    Mol Cell Biol; 1996 Jan; 16(1):359-68. PubMed ID: 8524315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth.
    Xin H; Pramanik R; Choubey D
    Oncogene; 2003 Jul; 22(31):4775-85. PubMed ID: 12894219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of E2F-mediated transcription by p202.
    Choubey D; Li SJ; Datta B; Gutterman JU; Lengyel P
    EMBO J; 1996 Oct; 15(20):5668-78. PubMed ID: 8896460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p202 prevents apoptosis in murine AKR-2B fibroblasts.
    Koul D; Lapushin R; Xu HJ; Mills GB; Gutterman JU; Choubey D
    Biochem Biophys Res Commun; 1998 Jun; 247(2):379-82. PubMed ID: 9642135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
    Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
    Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p202 self-associates through a sequence conserved among the members of the 200-family proteins.
    Koul D; Obeyesekere NU; Gutterman JU; Mills GB; Choubey D
    FEBS Lett; 1998 Oct; 438(1-2):21-4. PubMed ID: 9821952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine p202 protein, an IFN-inducible modulator of transcription, is activated by the mitogen platelet-derived growth factor.
    Flati V; Frati L; Gulino A; Martinotti S; Toniato E
    J Interferon Cytokine Res; 2001 Feb; 21(2):99-103. PubMed ID: 11244574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein.
    Choubey D; Lengyel P
    J Biol Chem; 1995 Mar; 270(11):6134-40. PubMed ID: 7890747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding properties of murine p53.
    Steinmeyer K; Deppert W
    Oncogene; 1988 Nov; 3(5):501-7. PubMed ID: 2978867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202.
    Datta B; Min W; Burma S; Lengyel P
    Mol Cell Biol; 1998 Feb; 18(2):1074-83. PubMed ID: 9448005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression.
    Lembo D; Angeretti A; Benefazio S; Hertel L; Gariglio M; Novelli F; Landolfo S
    J Biol Regul Homeost Agents; 1995; 9(2):42-6. PubMed ID: 9127631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
    Johnstone RW; Wei W; Greenway A; Trapani JA
    Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
    Nguyen H; Lin R; Hiscott J
    Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.